After 3 cycles of combination regimen of FFP (two units d0) rituximab (375 mg/m2 d0) and IL-2 (500,000 IU HD qod), the patient recovered from PNP and received IVIG (10 g) each month while her CLL kept stable. Here, IL2 is linked to B-cell chronic lymphocytic leukemia.